Skip to main content
Quest Diagnostics

Incidence of Pediatric Autoimmune Encephalitis Reported from a National Laboratory

AAN 2024

American Academy of Neurology

Denver, CO April 13-18, 2024

Poster presentation: Incidence of Pediatric Autoimmune Encephalitis Reported from a National Laboratory

Authors: Hooper J,  Racke M

Specialty: Neurology, Pediatrics, Immunology

Related content

Publication
Limbic encephalitis in a child with ovarian teratoma and influenza B. Case report and critical review of the history of autoimmune anti-N-methyl-d-aspartate receptor encephalitis
Test FAQ
Autoimmune Neurology
Publication
Atypical presentation of pediatric antiphospholipid syndrome
Publication
Current State of Pediatric Reference Intervals and the Importance of Correctly Describing the Biochemistry of Child Development: A Review
Audio Podcast
Patient-minded Neurology
Conference Presentation
Changes in Guillain-Barre Syndrome-Associated Ganglioside Antibody Test Results at a National Clinical Laboratory During the COVID-19 Pandemic

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.